Mandate

VINGE ADVISES LAGERKRANTZ GROUP IN CONNECTION WITH ACQUISITION OF CUE DEE

April 10, 2015

Vinge has advised Lagerkrantz Group in connection with the acquisition of Cue Dee AB from Anicho Invest AB. Cue Dee develops and sells durable and flexible fastenings which are used for, among other things, supporting mobile telecommunications units on masts, towers, roof tops and other exposed areas. The company’s head office is located in Robertsfors, north of Umeå and the company also has a subsidiary in China. The Cue Dee group has an annual turnover of approximately SEK 180 million and good liquidity.

Vinge’s team consisted of responsible partner Johan Winnerblad together with, among others, associates Filip Öhrner and Carl Sander.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024